Last reviewed · How we verify

NCT05846776: PRECISE

Preact to Lower the Risk of Falling by Customized Rehabilitation Across Europe: the PRECISE Study In Italy

Completed NA Last updated 8 September 2025
What this trial tests

NA trial testing DigiPrehab system in Elderly Subjects in 43 participants. Completed in 2 February 2024.

Timeline
26 October 2022
Primary endpoint
2 February 2024
2 February 2024

Quick facts

Lead sponsorIstituto Nazionale di Ricovero e Cura per Anziani
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment43
Start date26 October 2022
Primary completion2 February 2024
Estimated completion2 February 2024
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Istituto Nazionale di Ricovero e Cura per Anziani — full company profile →

Who can join

65 Months and older, any sex, with Elderly Subjects or Risk of Fall. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The PRECISE study is a 12-week pilot intervention study to evaluate the usability of the new DigiPrehab technology application in elderly subjects. The DigiPrehab system will enable the early identification of seniors with significant risk factors for falling and will propose an individualized physical training plan at home.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Preact to lower the risk of falling by customized rehabilitation across Europe: the feasibility study protocol of the PRECISE project in Italy.
    D'Ambrosio F, Harbo M, Contiero D, Bonfigli AR, et al · · 2024 · cited 2× · PMID 38584921 · DOI 10.3389/fpubh.2024.1293621

Verify or expand the search:

Other Istituto Nazionale di Ricovero e Cura per Anziani trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05846776.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing